Worth reading
66In focus
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3150000
sharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Substantial exercise of Series 5 warrants issued through a third-party allotment, with exercise price adjustment provisions
発行・処分する株式数
3,150,000 new shares (shares delivered since the beginning of November 2026)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
Exercise price adjustment provisions apply. The exercise price during the period was ¥58–¥69 (the adjustment floor is Not disclosed).
Number of Stock Acquisition Rights
Total issued: 280,000 warrants; exercised since the beginning of the month: 31,500; unexercised at present: 224,100
Most recent equity financing
Timing 14 October 2026 / Type Issuance of the Fifth Series of Stock Acquisition Rights with an Exercise Price Adjustment Clause / Amount Not disclosed, Timing 14 October 2026 / Type Issuance of Series 1 unsecured corporate bonds (privately placed bonds) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Substantial exercise of Series 5 warrants issued through a third-party allotment, with exercise price adjustment provisions |
| Number of shares to be issued or disposed of | 3,150,000 new shares (shares delivered since the beginning of November 2026) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Total number of issued shares | 117,300,220 shares (as of the end of the preceding month) → Not disclosed |
| Exercise price | Exercise price adjustment provisions apply. The exercise price during the period was ¥58–¥69 (the adjustment floor is Not disclosed). |
| Number of Stock Acquisition Rights | Total issued: 280,000 warrants; exercised since the beginning of the month: 31,500; unexercised at present: 224,100 |
| Most recent equity financing | Timing 14 October 2026 / Type Issuance of the Fifth Series of Stock Acquisition Rights with an Exercise Price Adjustment Clause / Amount Not disclosed, Timing 14 October 2026 / Type Issuance of Series 1 unsecured corporate bonds (privately placed bonds) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because a substantial exercise took place, to report the details. No further reason is stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.